Biomedicines (Jul 2023)

δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development

  • Natalia V. Naryzhnaya,
  • Alexander V. Mukhomedzyanov,
  • Maria Sirotina,
  • Leonid N. Maslov,
  • Boris K. Kurbatov,
  • Alexander S. Gorbunov,
  • Mikhail Kilin,
  • Artur Kan,
  • Andrey V. Krylatov,
  • Yuri K. Podoksenov,
  • Sergey V. Logvinov

DOI
https://doi.org/10.3390/biomedicines11071887
Journal volume & issue
Vol. 11, no. 7
p. 1887

Abstract

Read online

An analysis of published data and the results of our own studies reveal that the activation of a peripheral δ2-opioid receptor (δ2-OR) increases the cardiac tolerance to reperfusion. It has been found that this δ2-OR is localized in cardiomyocytes. Endogenous opioids are not involved in the regulation of cardiac resistance to reperfusion. The infarct-limiting effect of the δ2-OR agonist deltorphin II depends on the activation of several protein kinases, including PKCδ, ERK1/2, PI3K, and PKG. Hypothetical end-effectors of the cardioprotective effect of deltorphin II are the sarcolemmal KATP channels and the MPT pore.

Keywords